文献速递治疗药物监测与药物基因组学

结核病治疗药物监测与剂量调整的替代方法:系统综述

Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review.
PubMed 文献 · Clin Pharmacokinet · 2023-03-04

该系统综述纳入75项报告,评估干血斑、尿液、唾液和头发等替代生物基质用于抗结核药物浓度监测的可行性。干血斑可减少样本量并降低运输成本,尿液简单检测可在高负担地区实现即时检验,唾液预处理需求少,头发可检测多药及代谢物。现有数据多来自小规模研究,替代基质需在大型多样人群中验证,高质量干预研究将促进指南采纳和项目实施。

要点

  • 干血斑可减少样本量并降低运输成本,适合资源有限地区。
  • 尿液简单检测可在高结核病负担地区实现即时检验。
  • 替代生物基质需在大型多样人群中验证后方可推广。

核心结论

  • 干血斑、尿液、唾液和头发等替代生物基质有望改善结核病治疗药物监测的可行性,但现有数据多来自小规模研究,需在大型多样人群中验证。

研究设计与样本

  • 系统综述,纳入75项报告抗结核药物浓度测定的研究,涵盖干血斑、尿液、唾液和头发四种生物基质。

主要发现

  • 干血斑减少了样本量需求并降低了运输成本。
  • 尿液简单实验室方法可在高负担地区实现即时检验。
  • 唾液样本预处理需求少,可能提高实验室人员接受度。
  • 头发中已测试多分析物面板,可检测多种药物及部分代谢物。

临床怎么用

  • 在资源有限地区可考虑使用干血斑或尿液检测替代血清/血浆进行抗结核药物监测。
  • 替代生物基质的实施需结合当地实验室条件和人群验证结果。

局限性

  • 报告数据大多来自小规模研究。
  • 替代生物基质需在大型和多样人群中验证以证明操作可行性。
  • 需要高质量干预研究以促进指南采纳和项目实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Quantifying exposure to drugs for personalized dose adjustment is of critical importance in patients with tuberculosis who may be at risk of treatment failure or toxicity due to individual variability in pharmacokinetics. Traditionally, serum or plasma samples have been used for drug monitoring, which only poses collection and logistical challenges in high-tuberculosis burden/low-resourced areas. Less invasive and lower cost tests using alternative biomatrices other than serum or plasma may improve the feasibility of therapeutic drug monitoring. METHODS: A systematic review was conducted to include studies reporting anti-tuberculosis drug concentration measurements in dried blood spots, urine, saliva, and hair. Reports were screened to include study design, population, analytical methods, relevant pharmacokinetic parameters, and risk of bias. RESULTS: A total of 75 reports encompassing all four biomatrices were included. Dried blood spots reduced the sample volume requirement and cut shipping costs whereas simpler laboratory methods to test the presence of drug in urine can allow point-of-care testing in high-burden settings. Minimal pre-processing requirements with saliva samples may further increase acceptability for laboratory staff. Multi-analyte panels have been tested in hair with the capacity to test a wide range of drugs and some of their metabolites. CONCLUSIONS: Reported data were mostly from small-scale studies and alternative biomatrices need to be qualified in large and diverse populations for the demonstration of feasibility in operational settings. High-quality interventional studies will improve the uptake of alternative biomatrices in guidelines and accelerate implementation in programmatic tuberculosis treatment.

来源:Clin Pharmacokinet,查看原文。版权归原作者所有。

引用

  1. Rao PS, Modi N, Nguyen NT, et al. Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review. Clin Pharmacokinet. 2023. PMID: 36869170. doi:10.1007/s40262-023-01220-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。